Body composition dynamics and impact on clinical outcome in gastric and gastro-esophageal junction cancer patients undergoing perioperative chemotherapy with the FLOT protocol

被引：0
|
作者：
Florian Huemer
Stefan Hecht
Bernhard Scharinger
Verena Schlintl
Gabriel Rinnerthaler
Konstantin Schlick
Ronald Heregger
Thomas Melchardt
Angela Wimmer
Iris Mühlbacher
Oliver Owen Koch
Daniel Neureiter
Eckhard Klieser
Sara Seyedinia
Mohsen Beheshti
Richard Greil
Lukas Weiss
机构：
[1] Paracelsus Medical University Salzburg,Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute , Center for Clinical Cancer and Immunology
[2] Cancer Cluster Salzburg,CCCIT)
[3] Paracelsus Medical University Salzburg,Department of Radiology
[4] Paracelsus Medical University Salzburg,Department of Surgery
[5] Paracelsus Medical University Salzburg,Institute of Pathology
[6] Paracelsus Medical University Salzburg,Division of Molecular Imaging and Theranostics, Department of Nuclear Medicine
来源：
Journal of Cancer Research and Clinical Oncology | 2023年 / 149卷
关键词：
Gastric cancer; Perioperative chemotherapy; Sarcopenia; Skeletal muscle index; Body mass index;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3051 / 3064
页数：13
相关论文
共 50 条
  • [21] Updated results of perioperative PD-1 antibody toripalimab plus FLOT chemotherapy for locally advanced resectable gastric or gastro-esophageal junction adenocarcinoma: A one-arm open-table phase II trial
    Li, Hongli
    Ge, Shaohua
    Zang, Fenglin
    Ren, Peng
    Cao, Fuliang
    Liu, Rui
    Yang, Yuchong
    Ning, Tao
    Bai, Ming
    Wang, Xia
    Ji, Zhi
    Duan, Jingjing
    Liang, Han
    Ba, Yi
    Deng, Ting
    Deng, Jingyu
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [22] Perioperative toripalimab and chemotherapy in locally advanced gastric or gastro-esophageal junction cancer: a randomized phase 2 trial (Jan, 10.1038/s41591-023-02721-w, 2024)
    Yuan, Shu-Qiang
    Nie, Run-Cong
    Jin, Ying
    Liang, Cheng-Cai
    Li, Yuan-Fang
    Jian, Rui
    Sun, Xiao-Wei
    Chen, Ying-Bo
    Guan, Wen-Long
    Wang, Zi-Xian
    Qiu, Hai-Bo
    Wang, Wei
    Chen, Shi
    Zhang, Dong-Sheng
    Ling, Yi-Hong
    Xi, Shao-Yan
    Cai, Mu-Yan
    Huang, Chun-Yu
    Yang, Qiu-Xia
    Liu, Zhi-Min
    Guan, Yuan-Xiang
    Chen, Yong-Ming
    Li, Ji-Bin
    Tang, Xiong-Wen
    Peng, Jun-Sheng
    Zhou, Zhi-Wei
    Xu, Rui-Hua
    Wang, Feng
    NATURE MEDICINE, 2024, 30 (2) : 605 - 605
  • [23] Treatment-related frequency of venous thrombosis in lower esophageal, gastro-esophageal and gastric cancer - a clinical prospective study of outcome and prognostic factors
    Larsen, Anders Christian
    Frokjaer, Jens Brondum
    Fisker, Rune Vincents
    Iyer, Victor
    Mortensen, Peter Brondum
    Yilmaz, Mette Karen
    Moller, Bjarne
    Kristensen, Soren Risom
    Thorlacius-Ussing, Ole
    THROMBOSIS RESEARCH, 2015, 135 (05) : 802 - 808
  • [24] Preoperative nivolumab plus SOX in patients with locally advanced gastric or gastro-esophageal junction cancer: A phase 2, single-arm trial
    Cheng, Xiangdong
    Xu, Zhiyuan
    Hu, Can
    Zhang, Yanqiang
    Pengfei, Yu
    Du, Yian
    Yang, Litao
    Zhang, Ruolan
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [25] Outcome evaluation of ECF, DCF, FOLFOX, and FLOT chemotherapy regimens as perioperative treatment in elderly patients with resectable gastric cancer; A retrospective comparative study
    Forouhari, Ali
    Moghaddas, Azadeh
    Darakhshandeh, Ali
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2023, 28 (01):
  • [26] High impact of histopathological remission for prognosis after perioperative chemotherapy with Epirubicin, Cisplatin, 5-FU (ECF), and ECF - like regimens for gastric and gastro-esophageal adenocarcinoma
    Bichev, D.
    Treese, C.
    von Winterfeld, M.
    Daum, S.
    Thuss-Patience, P. C.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 121 - 122
  • [27] Economic evaluation of trifluridine/tipiracil (TT) versus nivolumab (N) in patients with advanced/metastatic gastric cancer (GC) or gastro-esophageal junction cancer (GEJC) in Canada
    Virik, Kiran
    Wilson, Robert B.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [28] High Clinical Impact of WATS3D Positive, but Forceps Biopsy Negative, Diagnoses at the Gastro-Esophageal Junction in Community Patients With GERD
    Srinivasan, Sachin
    Salyers, William J.
    Aravapalli, Amit
    McKinley, Matthew J.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S175 - S175
  • [29] Multi-center Phase II Trial of Weekly Paclitaxel Plus Cisplatin Combination Chemotherapy in Patients with Advanced Gastric and Gastro-esophageal Cancer
    Sun, Qing
    Liu, Chaoying
    Zhong, Haijun
    Zhong, Baoliang
    Xu, Haiyuan
    Shen, Wenxiang
    Wang, Daoyuan
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2009, 39 (04) : 237 - 243
  • [30] The Impact of the Radiation Dose Delivered to the Fundus and the Stomach on the Incidence of Anastomotic Complications for Patients with Gastro-Esophageal Junction Cancer Treated with Neoadjuvant Chemoradiotherapy and Surgery
    Ermenc, A. Secerov
    Hadzic, J. But
    Peressutti, A. Jeromen
    Anderluh, F.
    Oblak, I.
    Velenik, V.
    Srpcic, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E209 - E210
12345